...
首页> 外文期刊>ClinicoEconomics and Outcomes Research >Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe
【24h】

Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe

机译:优先考虑卫生系统和疾病负担因素:对将卫生技术干预措施转移到津巴布韦不同地区的净收益的评估

获取原文

摘要

Introduction: Health-care technologies (HCTs) play an important role in any country’s health-care system. Zimbabwe’s health-care system uses a lot of HCTs developed in other countries. However, a number of local factors have affected the absorption and use of these technologies. We therefore set out to test the hypothesis that the net benefit regression framework (NBRF) could be a helpful benefit testing model that enables assessment of intra-national variables in HCT transfer. Method: We used an NBRF model to assess the benefits of transferring cost-effective technologies to different jurisdictions. We used the country’s 57 administrative districts to proxy different jurisdictions. For the dependent variable, we combined the cost and effectiveness ratios with the districts’ per capita health expenditure. The cost and effectiveness ratios were obtained from HIV/AIDS and malaria randomized controlled trials, which did either a prospective or retrospective cost-effectiveness analysis. The independent variables were district demographic and socioeconomic determinants of health. Results: The study showed that intra-national variation resulted in different net benefits of the same health technology intervention if implemented in different districts in Zimbabwe. The study showed that population data, health data, infrastructure, demographic and health-seeking behavior had significant effects on the net margin benefit for the different districts. The net benefits also differed in terms of magnitude as a result of the local factors. Conclusion: Net benefit testing using local data is a very useful tool for assessing the transferability and further adoption of HCTs developed elsewhere. However, adopting interventions with a positive net benefit should also not be an end in itself. Information on positive or negative net benefit could also be used to ascertain either the level of future savings that a technology can realize or the level of investment needed for the particular technology to become beneficial.
机译:简介:医疗保健技术(HCT)在任何国家的医疗保健系统中都扮演着重要角色。津巴布韦的医疗保健系统使用其他国家/地区开发的许多HCT。但是,许多本地因素影响了这些技术的吸收和使用。因此,我们着手检验以下假设:净收益回归框架(NBRF)可能是一个有用的收益测试模型,该模型可以评估HCT转移中的国家内部变量。方法:我们使用NBRF模型来评估将具有成本效益的技术转移到不同司法管辖区的好处。我们使用了中国的57个行政区来代表不同的司法管辖区。对于因变量,我们将成本和有效性比率与各区的人均医疗支出相结合。成本和效果比来自艾滋病毒/艾滋病和疟疾随机对照试验,该试验进行了前瞻性或回顾性成本效益分析。自变量是健康的地区人口统计学和社会经济决定因素。结果:研究表明,如果在津巴布韦的不同地区实施同一医疗技术干预措施,那么国内差异会导致不同的净收益。该研究表明,人口数据,健康数据,基础设施,人口统计和寻求健康的行为对不同地区的净利润产生了重大影响。由于当地因素的影响,净收益在规模上也有所不同。结论:使用本地数据进行的净收益测试对于评估可移植性以及在其他地方开发的HCT的进一步采用是非常有用的工具。但是,采取具有正净收益的干预措施本身也不应该是目的。有关正净收益或负净收益的信息也可以用于确定一项技术可以实现的未来节省水平,或确定某项特定技术要实现收益所需的投资水平。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号